Please use this identifier to cite or link to this item:
|Title:||Is 67gallium dead? A retrospective review of 67gallium imaging in a single tertiary referral centre||Authors:||Ayesa, Sally ;Schembri, Geoffrey P||Affliation:||Central Coast Local Health District||Issue Date:||1-Apr-2021||Source:||42(4):378-388||Journal title:||Nuclear Medicine Communications||Department:||Radiology||Abstract:||[67Ga]Ga-citrate scanning has been used to investigate patients with known or suspected infection for over 50 years, continuing to maintain a clinical niche in many centres. The introduction of single photon emission tomography/computed tomography (SPECT/CT) in addition to planar imaging has improved the specificity of diagnosis. To examine the experience of modern [67Ga]Ga-citrate scanning in a single tertiary referral centre, considering the diagnostic yield of the study. A retrospective audit was undertaken of 100 consecutive [67Ga]Ga-citrate scans at Royal North Shore Hospital, Sydney. Recorded information included patient demographics, clinical information/history, and primary and secondary diagnoses. Subgroup analyses included patients with a confirmed diagnosis of infection or a suspected diagnosis of infection. The median age of patients was 68.5 years. Totally, 39/100 patients undergoing [67Ga]Ga-citrate scanning presented with a confirmed site of infection, with 2/6 patients with infective endocarditis and 5/12 patients with bacteraemia diagnosed with an additional, previously unknown, site of active infection (compared to 1/21 patients without documented bacteraemia). 61/100 patients did not have a confirmed site of infection before [67Ga]Ga-citrate scan (as per clinical history). 34/61 of these patients had a positive scan result for active infection/inflammation. Of 20 patients with a positive blood culture but no suspected site of infection, the source was identified in 9. [67Ga]Ga-citrate has diagnostic value in the evaluation of complex patients with high-risk infection. High diagnostic yield is demonstrated in patients with bacteraemia with or without a confirmed site of infection, particularly when combined with SPECT/CT.||URI:||https://hdl.handle.net/1/2340||DOI:||10.1097/MNM.0000000000001342||Pubmed:||https://pubmed.ncbi.nlm.nih.gov/33323867||Publicaton type:||Journal Article||Keywords:||Radiotherapy
|Appears in Collections:||Radiology|
Show full item record
checked on Jun 2, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.